(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.64%.
Sana Biotechnology's earnings in 2026 is -$241,987,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$174,934,093, with the lowest SANA earnings forecast at -$209,998,834, and the highest SANA earnings forecast at -$149,025,146. On average, 12 Wall Street analysts forecast SANA's earnings for 2027 to be -$172,819,077, with the lowest SANA earnings forecast at -$204,544,319, and the highest SANA earnings forecast at -$131,492,776.
In 2028, SANA is forecast to generate -$176,464,697 in earnings, with the lowest earnings forecast at -$204,544,319 and the highest earnings forecast at -$119,804,529.